Articles Tagged with Thimerosal

The DC Circuit released an opinion about vaccine safety this week. In Coal. for Mercury-Free Drugs v. Sebelius, the Court found that plaintiffs did not have standing to sue the FDA for failing to prohibit the use of vaccines containing the mercury-based preservative thimerosal on young children and pregnant women. The court concluded that plaintiffs were not required to receive thimerosal-preserved vaccines, they could readily obtain thimerosal-free vaccines, they did not have standing to challenge the FDA’s decision to allow other people to receive the vaccines, and plaintiffs could advocate that the Legislative and Executive Branches ban the vaccines. As a result, plaintiffs were suffering no cognizable injury as a result of the FDA’s decision to allow the vaccine, their lawsuit was not a proper subject for the Judiciary.